Anders D. Hove serves as Executive at Trubion Pharmaceuticals, Inc, where they oversee executive responsibilities. Since joining the company, Anders D. Hove has executed 60 insider transactions totaling $211.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 27, 2010 involved purchasing 306,071 shares valued at $3.4M.
Anders D. Hove currently holds 272,250 shares of Trubion Pharmaceuticals, Inc (TRBN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Anders D. Hove has been a net seller of TRBN stock. They have purchased $20.6M and sold $190.5M worth of shares.
Anders D. Hove's most recent insider trade was on Apr 27, 2010, when they purchased 306,071 shares at $11.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Apr 27, 2010 | ALIM | $0 | Conversion | 2,243,732 | $N/A | Discretionary |
| Jan 21, 2010 | WHRT | $2.0M | Purchase | 388,350 | $5.15 | Discretionary |
| Oct 23, 2006 | TRBN | $0 | Conversion | 1,483,474 | $N/A | Discretionary |
| Oct 23, 2006 | TRBN | $0 | Conversion | 36,450 | $N/A | Discretionary |
| Oct 23, 2006 | TRBN | $372.3K | Purchase | 28,637 | $13.00 | Discretionary |
| Oct 23, 2006 | TRBN | $9.2K | Purchase | 704 | $13.00 | Discretionary |
| Oct 23, 2006 | TRBN | $75.9K | Purchase | 5,840 | $13.00 | Discretionary |
| Oct 23, 2006 | TRBN | $0 | Conversion | 302,527 | $N/A | Discretionary |